San Francisco Police cancel time off requests to increase security at the J.P. Morgan Healthcare Conference after the recent murder of UnitedHealth Group CEO Brian Thompson. In the wake of the murder ...

Blue Shield of California issued a statement regarding the devastating wildfires that have spread across large sections of the state. 1 While the combination of flames and winds continue to cause ...

Priority Review was based on results from the Phase III Vivacity-MG3 study of nipocalimab in patients with generalized myasthenia gravis. The FDA has granted Priority Review to a Biologics License ...

‘Shape Shifting’ is a creator-led series that focuses on the scientific and cultural impact of GLP-1s. The two biggest stories in pharma in recent years have been the rise in popularity of GLP-1s and ...

Amylyx Pharmaceuticals named Dan Monahan as its chief commercial officer. 1 According to a press release, he is assuming the role in time to oversee the commercialization of avexitide, a GLP-1 ...

The campaign will include patient stories, education resources, and is being held in partnership with the Glaucoma Research Foundation. Bausch + Lomb announced the launch of the second annual Faces of ...

Mary Kosinski joined the firm as global managing director for the sector, along with other leadership additions. Mary Kosinski is the new global managing director of health and life sciences at ...

Abrysvo and Arexvy will now be required to come with labeling that includes a warning about a potential increased risk of Guillain-Barré Syndrome. The FDA announced that it has mandated updates to the ...

Swoop announced its acquisition of MyHealthTeam, creator of one of the largest opted-in patient social networks in the US. The companies share a vision of making vetted information more available for ...

Deloitte’s US life sciences sector leader discusses the trends he believes will have the most impact in 2025. According to a new report from Deloitte, the life sciences industry will have a ...

Both companies have produced AI-powered technology that improves data collection and analysis. As the pharma industry continues to embrace new technologies, it’s becoming increasingly clear that the ...

The future is bright with AI-powered innovations, but migration presents significant risks, including data loss, increased costs, and disruption to business operations. The life sciences industry is ...